Tandem Diabetes Care (TNDM) FCF Margin (2013 - 2026)

Tandem Diabetes Care has reported FCF Margin for 14 years, with the latest figure at 1.94% in Q1 2026.

• For the quarter ending Q1 2026, FCF Margin rose 1100.0% year-over-year to 1.94%; the trailing twelve-month figure through Mar 2026 stood at 0.35% (down 187.0% YoY), and the FY2025 full-year result was 2.92%, down 545.0% from the prior year.
• FCF Margin for Q1 2026 stood at 1.94%, up from 3.21% in the prior quarter.
• The five-year high for FCF Margin was 9.33% in Q4 2024, with the low at 13.22% in Q1 2023.
• Historically, FCF Margin has averaged 0.86% across 5 years, with a median of 2.6% in 2022.
• Annual changes were most pronounced in 2022 — FCF Margin sank 1966 bps — and 2024, when it jumped 1171 bps.
• Tandem Diabetes Care's FCF Margin stood at 0.09% in 2022, then surged by 6543 bps to 5.81% in 2023, then soared by 60 bps to 9.33% in 2024, then tumbled by 134 bps to 3.21% in 2025, then jumped by 160 bps to 1.94% in 2026.
• The last three FCF Margin figures came in at 1.94% (Q1 2026), 3.21% (Q4 2025), and 3.41% (Q3 2025), per Business Quant data.